PHI with Autoimmune hepatitis (AIH)
How does this condition affect your private health insurance?
Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease where the body's immune system mistakenly attacks its own liver cells, leading to inflammation and progressive damage. This condition, if left untreated, can advance to cirrhosis, liver failure, and potentially be fatal. It affects individuals of all ages and genders, frequently presenting with non-specific symptoms such as fatigue, jaundice, nausea, or joint pain, though some may be asymptomatic in early stages. Diagnosis relies on blood tests for liver enzymes and specific autoantibodies, coupled with a liver biopsy. Treatment primarily involves immunosuppressive medications like corticosteroids and azathioprine to control the immune response and prevent further liver deterioration. Early diagnosis and consistent adherence to treatment are vital for disease management and improving long-term outcomes.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Weeks to months for acute flares; often insidious onset leading to a chronic state.
Duration of Illness (Lifetime)
Chronic, lifelong disease requiring continuous management.
Cost of Treatment (Initial)
Estimated $10,000 - $50,000 for diagnosis, hospitalization, and initial high-dose immunosuppression, depending on severity and need for hospitalization.
Cost of Treatment (Lifetime)
Hundreds of thousands of dollars over a lifetime, including chronic medication, regular monitoring, and potential management of complications or liver transplantation.
Mortality Rate
Significant if untreated (e.g., 50% within 5 years); reduced to 10-20% within 10-20 years with treatment, often due to liver failure or complications.
Risk of Secondary Damages
High probability of cirrhosis (if untreated or poorly controlled), liver failure, hepatocellular carcinoma. Also, side effects from immunosuppression like infections, osteoporosis, or renal impairment.
Probability of Full Recovery
Very low; typically a chronic condition. Remission is achievable with treatment, but often requires lifelong medication and there's a risk of relapse.
Underlying Disease Risk
Moderate to high probability of co-occurrence with other autoimmune diseases such as ulcerative colitis, celiac disease, thyroiditis, rheumatoid arthritis, or primary sclerosing cholangitis.